Neurosurgical management of chronic pain and spasticity

Critical Reviews in Physical and Rehabilitation Medicine

Volumn 11, Issue 3-4, 1999, Pages 207-227

  Simpson, Richard K ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Ablative surgery; Chronic pain; Pharmacotherapy; Spasticity

Indexed keywords

4 AMINOBUTYRIC ACID; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; BENZODIAZEPINE DERIVATIVE; CATECHOLAMINE; GLYCINE; INDOLEAMINE; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE;

BRAIN DEPTH STIMULATION; CHRONIC PAIN; CORDOTOMY; GANGLIONECTOMY; NERVE STIMULATION; NEURECTOMY; NEUROLYSIS; NEUROMODULATION; PATIENT SELECTION; PRIORITY JOURNAL; REVIEW; RHIZOTOMY; SPASTICITY; SPINAL CORD STIMULATION; SURGICAL TECHNIQUE; TENOTOMY; THALAMOTOMY; TREATMENT OUTCOME;

EID: 0032870605     PISSN: 08962960     EISSN: None     Source Type: Journal    
DOI: 10.1615/critrevphysrehabilmed.v11.i34.20     Document Type: Review

References (201)

1. Balter, K., Tutorial 8: a review of pain anatomy and physiology, Pain Digest, 11, 306-330, 1992.
2. Bennet, J. P., Logan, W. J., and Snyder, S. H., Amino acid as central nervous system transmitters: the influence of ions, amino acid analogues, and ontogeny on transport systems for 1-glutamate and D-depatic acids and glycine into the central nervous synaptosomes of the rat, J. Neurochem., 21, 1533-1550, 1973.
3. Boakes, A. J., Laurence, D. R., Teoh, P. C., Barar, F. S. K., Benedikter, L. T., and Prichard, B. N. C., Interactions between sympathomimetic amines and antidepressant agents in man, Br. Med. J., 1, 311-315, 1973.
4. Raft, D., Davidson, J., Wasik, J., and Mattox, A., Relationship between response to phenelzine and MAO inhibition in a clinical trial of phenelzine, amitriptyline, and placebo, Neuropsychobiology, 7, 122-126, 1981.
5. Roger, K. J., Role of brain monoamines in the interaction between pethidine and tranylcypromine, Eur. J. Pharmacol., 14, 86-88, 1971.
6. Sewell, R. D. E. and Spencer, P. S. J., Modification of the antinociceptive activity of narcotic agonists and antagonists by intraventricular injection of biogenic amines in mice, Br. J. Pharmacol., 51, 140-141, 1974.
7. Hokfelt, T., Jonsson, G., and Linbrink, P., Electron microscope identification of monoamine nerve ending particles in rat brain homogenates, Brain Res., 22, 147-151, 1970.
8. Pasternak, G. W., Multiple morphine and enkephalin receptors and their relief of pain, JAMA, 259, 1362-1367, 1988.
9. Pert, C. and Snyder, S., Opiate receptor: demonstration in nervous tissue, Science, 179, 1011-1014, 1973.
10. Snyder, S., The opiate receptor and morphine-likepeptides in the brain, Am. J. Psychiatr., 135, 645-652, 1978.
11. Hosobuchi, Y., Adams, J., and Linchitz, R., Pain relief by electrical stimulation of the central gray matter in humans and its reversal by naloxone, Science, 197, 183-186, 1977.
12. Notl, M. W., Potentiation of morphine analgesia by cocaine in mice, Eur. J. Pharmacol., 5, 93-99, 1968.
13. Palmer, H., Potentiation of pethidine, Br. Med. J., 2, 944, 1960.
14. Hendler, N., The Diagnosis and Nonsurgical Management of Chronic Pain, Raven Press, New York, 1981.
15. Gropetti, A., Braga, P. C., Biella, G., Parenti, M., Rusconi, L., et al., Effect of aspirin on serotonin and met-enkephalin in brain: correlation with the antinociceptive activity of the drug, Neuropharmacology, 27, 499-505, 1988.
16. Klipper, A. and Kolodny, A. L., Nonsteroidal antiinflammatory drugs, in Diagnosis and Treatment of Chronic Pain, Hendler, N., Long, L. J., and Wise, T., Eds., Wright-PSG, Littletown, MA, 1982, 183-192.
17. Lanza, F. L., Gastrointestinal toxicity of newer NSA1Ds, Am. J. Gastroenterol., 88, 1318-1323, 1993.
18. Walt, R. D., Misoprotol for the treatment or peptic ulcer and antiinflammatory drug induced gastro-duedenal ulceration, N. Engl. J. Med., 327, 1575-1580, 1992.
19. Abramson, S., Therapy with and mechanisms of non-steroidal antiinflammatory drugs, Curr. Opin. Rheun., 3, 336-340, 1991.
20. Halpern, L. M., Analgesic and antiinflammatory medications, in Handbook of Chronic Pain Management, Tollison, C. D., Ed., Williams & Wilkins, Baltimore, 1989, 54-68.
21. Gaucher, A., Netter, P., Faure, G., Schoeller, J. P., and Gerardin, A., Diffusion of oxyphenbutazone into synovial fluid, synovial tissue, joint cartilage, and cerebrospinal fluid, Eur. J. Clin. Pharmacol., 25, 107-112, 1983.
22. Frolich, J. C., Leftwich, R., Ragheb, M., Oates, J. A., Reimann, I., and Buchanan, D., Indomethacin increases plasma lithium, Br. Med. J., 1, 1115-1116, 1979.
23. Green, Given, K. M., Tsao, C., Ehipple, J. P., and Rossi, E. C., The effect of a new nonsteroidal antiinflammatory agent, sulindac, on platelet function, Thromb. Res., 10, 283-289, 1977.
24. Watcha, M. F., Jones, M. B., Laguerela, R. G., Schweiger, C., and White, P. F., Comparison of ketorolac and morphine as adjuvants during pediatric surgery, Anesthesiology, 76, 368-372, 1992.
25. Welch, K. M., Ellis, D. J., and Keenan, P. A., Successful migraine prophylaxis with naproxen sodium, Neurology, 35, 1304, 1985.
26. Kantor, T. C., Ibuprofen, Ann. Intern. Med., 91, 877-883, 1979.
27. Troullos, E. S., Hargreaves, K. M., Butler, D. P., and Dionne, R. A., Comparison of nonsteroidal antiinflammatory drugs, ibuprofen and furbiprofen, with methylprednisolone and placebo for acute pain, swelling, and trismus, J. Oral Maxillofac. Surg., 48, 945-952, 1990.
28. Cooper, S. A. and Kupperman, A., The analgesic efficacy of furbiprofen compared to acetaminophen with codeine, J. Clin. Den., 2, 70-74, 1991.
29. Anthony, M. and Lance, J. W., Monoamine oxidase inhibitors in the treatment of migraine, Arch. Neurol., 21, 263-268, 1969.
30. Max, M. F., Lynch, S. A., Muir, J., Shoaf, S. E., and Smoller, B., Dubner effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic nenlopathy, N. Engl. J. Med., 326, 1250-1256, 1992.
31. Chapman, C. R. and Butler, S. H., Effects of doxepin on perception of laboratory-induced pain in man, Pain, 5, 253-262, 1978.
32. Malseed, R. and Goldstein, F. J., Enhancement of morphine analgesia by tricyclic antidepressants, Neuropharmacology, 18, 827-829, 1979.
33. Richelson, G., Side effects of old and new generation antidepressants: a pharmacological framework, J. Clin. Psychiatr. Monogr., 9, 13-19 1991.
34. Taub, A., Relief of post-herpetic neuralgia with psychotropic drugs, J. Neurosurg., 39, 235-239, 1973.
35. Goldstein, F. J., Mojaverian, P., Ossipov, M. H., and Swanson, B. N., Elevation in analgesic effect and plasma levels of morphine by desipramine in rats, Pain, 14, 279-282, 1982.
36. Hall, R., Hall, A. K., Gardner, E. R., et al., Effectiveness of Tricyclic Antidepressants in the Management of Chronic Pain. Academy of Psychosomatic Medicine, San Francisco, CA, October, 1979.
37. Jakubovic, A., Psychoactive agents and enkephalin degradation. In Endorphins and Opiate Antagonists in Psychiatric Research: Clinical Implications, Nandkumar, S. and Alexander, D., Eds., Plenum, New York, 1982, 8997.
38. Kvinesdal, B., Molin, J., Froland, A., and Gram, L. F., Imipramine treatment of painful diabetic neuropathy, JAMA, 251, 1727-1730, 1984.
39. Levine, J. D., Gordon, N. C., Smith, R., and McBryde, R., Desipramine enhances opiate postoperative analgesia, Pain, 27, 45-49, 1986.
40. Lindsay, P. G. and Olsen, R. B., Maprotiline in pain-depression, J. Clin. Psychiatry, 46, 226-228, 1985.
41. Bromm, B. and Seide, K., The influence of tilidine and prazepam on withdrawal reflex, skin resistance reaction and pain rating in man, Pain, 12, 247-258, 1982.
42. Taub, A., The use of psychotropic drugs alone and adjunctively in the treatment of otherwise intractable pain: post-therapeutic neuralgia: disseminated visceral neoplasm, in Pain, Voris, N. C. and Whisler, W. W., Eds., Charles C. Thomas, Springfield, 1975.
43. Montillia, E., Frederick, W. S., Cass, L. J., Analgesic effects of methotrimeprazine and morphine: a clinical comparison, Arch. Intern. Med., 111, 275-278, 1963.
44. Hendler, N., Benzodiazepines: mechanism of action and appropriate use, in Life Stress - A Companion to the Life Sciences, Day, S., Ed., Van Nostrand Reinhold, New York, 1982.
45. Jenkins, D. G., Ebbutt, A. F., and Evans, C. D., Tofranil in the treatment of low back pain, J. Int. Med. Res., 4(Suppl. 2), 28-40, 1976.
46. Marks, J., Benzodiazepines - For good or evil, Neuropsychobiology, 10, 115-126, 1983.
47. Hendler, N., Cimini, C., Ma, R., and Long, D., The comparison between cognitive impairment due to benzodiazepines and narcotics, Am. J. Psychiatry, 137, 828-830, 1980.
48. Rickels, K., Case, W. G., and Diamond, L., Issues in long-term treatment with diazepam therapy, Psychopharmacol. Bull., 18, 38-41, 1982.
49. Bromm, B., Meier, W., and Scharein, E., Imipramine reduces experimental pain, Pain, 25, 245-257, 1986.
50. Caccia, M. R., Clonazepam in facial neuralgia and cluster headache. Clinical and electrophysiological study, Eur. Neurol., 13, 560-563, 1975.
51. Browne, T. R., Empting, L., Lydiard, R. B., and Yerby, M. S., New uses and old for carbamazepine, Patient Care, 24, 48-81, 1990.
52. Zivkovic, B., Perrault, G., Morel, E., et al., Comparative Pharmacology or Zolpidem and Other Hypnotics and Sleep Inducers in Imidazopyridines in Sleep Disorders, Sauvanet, J. P., Kanger, S. Z., and Morselli, P. L., Eds., Raven Press, New York, 1988, 97-110.
53. Depoortere, H., Zivkovic, B., Lloyd, K. G., et al., Zolpidem, a novel nonbenzodiazepine hypnotic: neuropharmacological and behavioral effects, J. Pharmacol. Exp. Ther., 237, 649-658, 1986.
54. Oswald, I. and Adam, K., A new look at short acting hypnotics, in Imidagopyridines in Sleep Disorder, Sauvanet, J. P., Kanger, S. Z., and Morselli, P. L., Eds., Raven Press, New York, 1988, 253-259.
55. Scharf, M. B., Mayleben, O. W., Kaffeman, M., et al., Dose response effects of zolpidem in normal geriatric subject, J. Clin. Psychiatry, 52, 77-83, 1991.
56. Walsh, J. K., Schweitzer, P. K, Sugerman, J. L., et al., Transient insomnia associated with a three hour phase advance of sleep time and treatment with zolpidem, Clin. Psychopharmacol., 10, 184-189, 1990.
57. Jackson, G. L. and Smith, D. A., Analgesia properties of mixtures of chlorpromazine with morphine and meperidine, Ann. Intern. Med., 45, 640-652, 1956.
58. Kantor, T. G. and Steinburg, F. P., Studies of tranquillizing agents (hydroxyzine and meproblmate) and meperidine in clinical pain, in Advances in Pain Research and Therapy, vol. 1, Bonica, J. J. and Alge-Fessard, D., Eds., Raven Press, New York, 1976, 507-572.
59. Keats, A. S, Telford, J., and Kurosu, Y., "Potentiation" of meperidine by promethazine, Anesthesiology, 22, 34-41,1966.
60. Pasternak, G., Psychotropic drugs and chronic pain, in Diagnosis and Treatment of Chronic Pain, Hendler, N., Long, D., and Wise, T., Eds., Wright-PSG, Littletown, MA, 1982, 201-210.
61. Hakkarainen, H., Fluphenazine for tension headache: a double-blind study, Headache, 17, 216-218, 1977.
62. Iserson, K. V., Parenteral chlorpromazine treatment of migraine, Ann. Emer. Med., 12, 756-758, 1983.
63. Lasagna, L. and DeKornfeld, T. J., Methotrimeprazine - A new phenothiazine derivative with analgesic properties, JAMA, 178, 887-890, 1961.
64. Maltbie, A. A. and Cavenar, J. O., Haloperidol and analgesia, Milt. Med., 142, 946-948, 1977.
65. Giles, T. O. and Modlin, R. K., Death associated with ventricular arrhythmias and thioridazine hydrochloride, JAMA, 205, 108-110, 1968.
66. Schug, S. A., Merry, A. P., and Acland, R. H., Treatment principles for the use of opioids in pain of nonmalignant origin, Drugs, 42, 228-239, 1991.
67. Kanner, R. and Foley, K., Patterns of Narcotic Drug Use in a Cancer Pain Clinic, Millman R, Crohman P., Jr., and Lowinson, J., Eds., Ann. N.Y. Acad. Sci., 362, 161-172, 1981.
68. Hoskin, P. J. and Hanks, G. W., Opioid agonist-antagonist drugs in acute and chronic pain states, Drugs, 41, 326-344, 1991.
69. Portenoy, R. K. and Farkash, A practical management of nonmalignant pain in the elderly, Geriatrics, 43, 29-47, 1988.
70. DeVaul, R., Hall, R., and Faillace, L., Drug use by the polysurgical patient, Am. J. Psychiatry, 135, 682-685, 1978.
71. Twycross, R., Narcotic analgesics in clinical practice, in Advances in Pain Research and Therapy, Bonica, J., Lindblom, L., and Iggo, A., Eds., Raven Press, New York, 1983, 5, 435-459.
72. Bruera, E., Fainsinger, R., and MacEachern, J. H., The use of methylphenidate in patients with incident cancer pain receiving regular opiates. A preliminary report, Pain, 50, 75-77, 1992.
73. Goetzl, F. R., Burrill, D. Y., and Ivy, A. C., The analgesic effect of morphine alone and in combination with dextroamphetamines, Proc. Soc. Exp. Biol. Med., 55, 248-250, 1944.
74. Head, M., Lal, H., and Puri, S., Enhancement of morphine analgesia after acute and chronic haloperidol, Life Sci., 24, 2037-2043, 1979.
75. Ivy, A. C., Goetzl, F. R., and Burril, D. Y., Morphilledextroamphetamine analgesia, War Med., 6, 67-71, 1944.
76. Rivers, N. and Hornes, P., Possible lethal reaction between nardil and dextromorphan, Can. Med. Assoc. J., 103, 85, 1970.
77. Shee, J. C., Dangerous potentiation of pethidine by ipronazid and its treatment, Br. Med. J., 2, 507-509, 1960.
78. Melzack, R., A tragedy of needless pain, Sci. Am., 262, 27-33 1990.
79. Portenoy, R. K., Chronic opiate therapy and non-malignant pain, J. Pain Symp. Manage., 5(suppl.), 46-62, 1990.
80. Twycross, R. G. and Fairfield, S., Pain in far advanced cancer, Pain, 14, 303-310, 1982.
81. Hering, R. and Kuritzky, A., Sodium valproate in the prophyactic treatment of migraine: a double-blind study versus placebo, Cephalalgia, 12, 81-84,1992.
82. Mathew, N. T. and Ali, S., Valproate in the treatment of persistent chronic daily headache. An open label study, Headache, 31, 71-74, 1991.
83. Swerdlow, M. and Cundill, J. G., Anticonvulsant drugs used in the treatment of lancinating pain. A comparison, Anesthesia, 36, 1129-1132, 1981.
84. Sandford, P. R., Lindblom, L. B., and Haddox, J. D., Amitriptyline and carbamazepine in the treatment of dysesthetic pain in spinal cord injury, Arch. Phys. Med. Rehab., 73(3), 300-301, 1992.
85. Edmondson, E. A., Simpson, R. K., Beric, A., and Stubler, D. K., Systemic lidocaine therapy for "thalamic pain", South Med. J., 86, 1093-1096, 1993.
86. Colclough, G. et al., Mexiletine for chronic pain (Letter), Lancet, 342, 1484-1485, 1993.
87. Bernstein, J. E., Bickers, D. R., Dahl, M. V., and Roshal, J. Y., Treatment of chronic postherpetic neuralgia with topical capsaicin, J. Am. Acad. Derm., 17, 93-96, 1987.
88. Ross, D. R. and Varipapa, R. J., Treatment of painful diabetic neuropathy with topical capsaicin, N. Engl. J. Med., 321, 474-475, 1989
89. Bakris, G. L., Mulopulos, G. P., Subhash, T., and Franklin, C., Orphenadrine citrate: an effective alternative for muscle contraction headaches, Med, 116, 106-108, 1982.
90. Chiou-Tan, F. Y., Tuel, S. M., Johnson, J. C., Priebe, M. M., Hirsh, D. D., and Strayer, J. R., Effect of mexiletine on spinal cord injury dysesthetic pain, Am. J. Phys. Med. Rehab., 75(2), 84-87, 1996.
91. Maurer, M., Henn, V., Dittrich, A., and Hofmànn, A., Delta-9-tetrahydrocannabinol shows antispastic and analgesic effects in a single case double-blind trial, Eur. Arch. Psych. Neurol. Sci., 240(1), 1-4, 1990.
92. Parmar, B. S., Shah, K. H., and Gandhi, I. C., Baclofen in trigeminal neuralgia - a clinical trial, JDR, 1, 109-113, 1989.
93. Barolat-Romana G. and Davis, R., Neurophysiological mechanisms in abnormal reflex activities in cerebral palsy and spinal spasticity, J. Neurol. Neurosurg. Psychiat., 43, 333-342, 1980.
94. Rymer, W. Z. and Powers, R. K., Pathophysiology of muscular hypertonia in spasticity, in Management of Spasticity in Cerebral Palsy and Spinal Cord Injury. State of the Art Reviews, Neurosurgery, vol. 4, Park, T. S., Phillips, L. H., and Peacock, W. J., Eds., Hanley & Belfus, Inc. Philadelphia, 1989, 291-301.
95. Davidoff, R. A., Antispasticity drugs: mechanism of action, Ann. Neurol., 17, 107-116, 1985.
96. Davidoff, R. A., Mode of action of antispasticity drugs, in Management of Spasticity in Cerebral Palsy and Spinal Cord Injury, Neurosurgery, State of the Art Review, vol. 4, no. 2, Park, T. S., Phillips, L. H., and Peakock, W. J., Hanley & Belfus, Inc. Philadelphia, 1989, 315-324.
97. Hunt, S. P., Cytochemistry of the spinal cord, in Chemical Neurochemistry, Emson, P. C., Ed., Raven Press, New York, 1983, 53-84.
98. Fox, S., Krnjevic, K., Morris, M. E., et al., Action of baclofen on mammalian synaptic transmission, Neuroscience, 3, 495, 1978.
99. Ashby, P. and McCrea, D. A., Neurophysiology of spasticity, in Handbook of the Spinal Cord, Congenital Disorders and Trauma, vol. 4, chap. 5, Davidoff, R. A., Ed., Marce Dekker, Inc., New York, 1987, 119-143.
100. Delwaide, P. J., Electrophysiological analysis of the mode of aciton of muscle relaxants in spasticity, Ann. Neurol., 17, 90-95, 1985.
101. Fagg, G. E. and Foster, A. C., Amino acid neurotransmitters and their pathways in the mammalian central nervous system, Neuroscience, 9, 701-719, 1983.
102. Penn, P. D., Savoy, S. M., Corcos, D., Latash, M., Gottlieb, G., Parke, B., and Kroin, J. S., Intrathecal baclofen for severe spinal spasticity, N. Engl. J. Med., 320, 1517-1521, 1989.
103. Penn, R. D., Intrathecal infusion of baclofen for spasticity: the RUSH and the U.S. multicenter studies, in Neurosurgery for Spasticity, Sindou, M., Abbott, R., and Keravel, Y., Eds., Spinger-Verlag, New York, 1991, 103-109.
104. Loubser, P. G. and Akman, N. M., Effects of intrathecal baclofen on chronic spinal cord injury pain, J. Pain Symp. Mgmt., 12(4), 241-247, 1996.
105. Albright, A. L., Cervi, A., and Singletary, J., Intrathecal baclofen for spasticity in cerebral palsy, JAMA, 265, 1418-1422, 1991.
106. Rudick, R. A., Breton, D., and Krall, R. L., The GABA-agonist progabide for spasticity in multiple sclerosis, Arch. Neurol., 44, 1033-1036, 1987.
107. Fryda-Kaurimsky, Z. and Muller-Fassbender, H., Tizanidine in the treatment of acute paravertebral muscle spasm, J. Int. Med. Res., 9, 501-505, 1981.
108. Mathias, C. J., Luckitt, J., Desai, P., Baker, H., Masri, W. E., Frankel, H. L., Pharmacodynamics and pharmacokinetics of the oral antispatic agent tizanidine in patients with spinal cord injury, J. Rehab. Res. Dev., 26, 916, 1989.
109. Turski, L., Schwarz, M., Turski, W. A., Klockgether, T., Sontag, K. H., and Collins, J. F., Muscle relaxant action of excitatory amino acid antagonists, Neurosci. Lett., 53, 321-326, 1985.
110. Larson, A. A., Intrathecal GABA, glycine, taurine or beta-alanine elicits dyskinetic movements in mice, Pharmacol. Biochem. Behav., 32, 505-509, 1989.
111. Scheardown, M. J., Drejer, J., Jensen, L. H., Stidsen, C. E., and Honore, T., A potent antagonist of the strychnine inbsensitive glycine receptor has anticonvulsant properties, Eur. J. Pharmacol., 174, 197-204, 1989.
112. Zachariah, S. B., Borges, E. F., Varghese, R., Cruz, A. R., and Ross, G. S., Positive response to oral divalproex sodium (Depakote) in patients with spasticity and pain, Am. J. Med. Sci., 308(1), 38-40, 1994.
113. Aprison, M. H., The discovery of the neurotransmitter role of glycine, in Glycine Neurotransmission, Ottersen, O. P. and Storm-Mathisen, J., Eds., John Wiley & Sons Ltd., 1990, 1-23.
114. Daly, E. C. and Aprison, M. H., Glycine. Handbook of Neurochemistry, Lajtha, A., Ed., Plenum Press, New York, 1983, 467-499.
115. Curtis, D. R., Duggan, A. W., and Johnston, G. A. R., The specificity of strychnine as a glycine antagonist in the mammalian spinal cord, Exp. Brain Res., 12, 547-565, 1971.
116. Young, A. B. and Macdonald, R. L., Glycine as a spinal cord neurotransmitter, in Handbook of the Spinal Cord; Pharmacology, vol. 1, Davidoff, R. A., Ed., Marcel Dekker Inc., New York, 1987, 1-44.
117. Young, A. B. and Snyder, S. H., Strychnine binding associated with glycine receptors of the central nervous system, Proc. Natl. Acad. Sci. U.S.A., 70, 2832-2836, 1973.
118. Lester, R. A. J., Tong, G., and Jahr, C. E., Interactions between the glycine and glutamate binding sites of the NMDA receptor, J. Neurosci., 13, 1088-1096, 1993.
119. Simpson, R. K., Jr., Gondo, M. M., Robertson, C. S., and Goodman, J. C., The influence of glycine and related compounds on spinal cord injury induced spasticity, Neurochem. Res., 20, 1203-1210, 1995.
120. Simpson, R. K., Jr., Gondo, M. M., Robertson, C. S., and Goodman, J. C., Reduction in the mechanonociceptive response by intrathecal administration of glycine and related compounds, Neurochem. Res., 21, 1221-1226, 1996.
121. Simpson, R. K., Jr., Gondo, M. M., Robertson, C. S., and Goodman, J. C., Reduction in thermal hyperalgesia by intrathecal administration of glycine and related compounds, Neurochem. Res., 22, 75-79, 1997.
122. Barbeau, A., Preliminary study of glycine administration in patients with spasticity, Neurology, 24, 392, 1974.
123. Hall, P. V., Smith, J. E., Lane, J., Mote, T., and Campbell, R., Glycine and experimental spinal spasticity, Neurology, 29, 262-267, 1979.
124. Smith, J. E., Hall, P. V., Galvin, M. R., Jones, A. R., and Campbell, R. L., Effects of glycine administration on canine experimental spinal spasticity and the levels of glycine, glutamate, and aspartate in the lumbar spinal cord, Neurosurgery, 4, 152-156, 1979.
125. Beyer, C., Banas, C., Gomora, P., and Komisaruk, B. R., Prevention of the convulsant and hyperalgesic action of strychnine by intrathecal glycine and related amino acids, Pharmacol. Biochem. Behav., 29, 73-78, 1988.
126. Beyer, C., Banas, C., Gonzalez-Flores, O., and Komisaruk, B. R., Blockage of substance P-induced scratching behavior in rats by the intrathecal adminstration of inhibitory amino acid agonists, Pharmacol. Biochem. Behav., 34, 491-495, 1989.
127. Gold, R. H., Orphenadrine citrate in low-back pain, Clin. Trial J., 15, 145-149, 1978.
128. Gready, D. M., Parafon Forte vs. Robaxisal in skeletal muscle disorders: a double-blind study, Curr. Ther. Res., 20, 666-673, 1976.
129. Bergen, F. M., Kletztein, M., Ludwig, B. J., and Margolin, S., History, chemistry, and pharmacology of carisoprodol, Ann. N.Y. Acad. Sci., 86, 90-107, 1960.
130. Dent, R. W. and Ervin, D. K., A study of metaxalone (Skelaxin) vs. placebo in acute musculoskeletal disorders, Curr. Ther. Res., 18, 433-440, 1975.
131. Hindle, T. H., Comparison of carisoprodol, butalbital, and placebo in treatment of the low back syndrome, Calif. Med., 117, 7-11, 1972.
132. Share, N. N. and McFarlane, C. S., Cyclobenzaprine: a novel centrally acting skeletal muscle relaxant, Neuropharmacology, 4, 675, 1975.
133. Tisdale, S. A. and Ervin, D. K., A controlled study of methocarbamol (Robaxin) in acute painful musculoskeletal conditions, Curr. Ther. Res., 17, 524-530, 1975.
134. White, J. C. and Sweet, W. H., Pain and the Neurosurgeon. A Forty-Year Experience, Charles C. Thomas, Springfield, Illinois, 1969.
135. Sweet, W. H. and Poletti, C. E., Operations in the brain stem and spinal canal, with an appendix on open cordotomy, in Textbook of Pain, Wall, P. D. and Melzack, R., Eds., Churchill Livingstone, New York, 1989, 811-831.
136. Bonica, J. J., Local anaestheisa and regional blocks, in Textbook of Pain, Wall, P. D. and Melzack, R., Eds., Churchill Livingstone, New York, 1989, 724-743.
137. Herz, D. A., Looman, J. E., Tiberio, A., Ketterling, K., Kreitsch, R. K., Colwill, H. C., and Grin, O. D., The management of paralytic spasticity, Neurosurgery, 26, 300-306, 1990.
138. Mathe, J. F. and Richard, L., Physical treatments of spasticity and chemical blocks, in Neurosurgery for Spasticity, Sindou, M., Abbott, R., and Keravel, Y., Eds., Spinger-Verlag, New York, 1991, 63-69.
139. Wood, K. M., Peripheral nerve and root chemical lesions, in Textbook of Pain, Wall, P. D. and Melzack, R., Eds., Churchill Livingstone, New York, 1989, 768-772.
140. Segnarbieux and Frerebeau, P., The different (open surgical, percutaneous thermal, and intrathecal chemical) rhizotomies for the treatment of spasticity, in Neurosurgery for Spasticity, Sindou, M., Abbott, R., and Keravel, Y., Eds., Spinger-Verlag, New York, 1991, 133-139.
141. Mertens, P. and Sindou, M., Selective peripheral neurotomies for the treatment of spasticity, in Neurosurgery for Spasticity, Sindou, M., Abbott, R., and Keravel, Y., Eds., Spinger-Verlag, New York, 1991, 119-132.
142. Foerster, O., Uber eine neue operative methode der behandlung spastischer lahmungen mittels tesektion hinterer ruckenmarkswurzeln, A. Orthop, Chir., 22, 203-213, 1908.
143. Retif, J., Intrathecal injection of a neurolytic solution for the relief of intractable pain, in Advances and Technical Standards in Neurosurgery, Krayenbuhl, H., Ed., Springer-Verlag, New York, 1977, 43-64.
144. Dubuisson, D., Root surgery, in Textbook of Pain, Wall, P. D. and Melzack, R., Eds., Churchill Livingstone, New York, 1989, 7784-794.
145. Hassenbusch, S. J., Stanton-Hicks, M., Schoppa, D., Walsh, J. G., and Covington, E. C., Long-term results of peripheral nerve stimulation for reflex sympathetic dystrophy, J. Neurosurg., 84, 415-423, 1996.
146. Hosobuchi, Y., The majority of unmyelinated afferent axons in human ventral roots probably conduct pain, Pain, 8, 167-180, 1980.
147. Verrill, P., Sympathetic ganglion lesions, in Textbook of Pain, Wall, P. D. and Melzack, R., Eds., Churchill Livingstone, New York, 1989, 7773-7783, 1989.
148. Abbott, R. and Johann-Murphy, M., Selective functional rhizotomy for the treatment of spasticity in children, in Neurosurgery for Spasticity, Sindou, M., Abbott, R., and Keravel, Y., Eds., Spinger-Verlag, New York, 1991, 149-157.
149. Privat, J. M., Benezech, J., Frerebeau, P., and Gros, C., Sectorial posterior rhizotomy. A new technique of surgical treatment of spasticity, Acta Neurochir., 35, 181-195, 1987.
150. Nashold, B. S., Jr., Neurosurgical technique of the dorsal root entry zone operation, Applied Neurophysiol., 51, 136-145, 1988.
151. Nashold, B. S., Jr. and Ostdahl, R. H., Dorsal root entry zone lesions for pain relief, J. Neurosurg., 51, 59-69, 1979.
152. Sindou, M. and Jeanmonod, D., Surgery in the dorsal root entry-zone: microsurgical DREZ-tomy (MDT) for the treatment of spasticity, in Neurosurgery for Spasticity, Sindou, M., Abbott, R., and Keravel, Y., Eds., Spinger-Verlag, New York, 1991, 165-182.
153. Sindou, M. and Mertens, P. L., Indications for surgery to treat adults with harmful spasticity, in Neurosurgery for Spasticity, Sindou, M., Abbott, R., and Keravel, Y., Eds., Spinger-Verlag, New York, 1991, 121-213.
154. Sindou, M., Pregelj, R., Boisson, D., Eyssetet, M., and Goutelle, A., Surgical selective lesions of nerve fibers and myelotomies for modifying muscle hypertonia, In Recent Achievements in Restorative Neurology, Upper Motor Neuron Functions and Dysfunctions, Eccles, J. and Dimitrijevic, M. R., Eds., Basel, Karger, 1985, 10-26.
155. Hyndman, O. R., Lissauer's tract section; a contributions to chordotomy for the relief of pain. Preliminary report, J. International Coll. Surg., 5, 394-400, 1942.
156. Jefferson, A., Cordectomy for intractable pain, in Persistent Pain, Lipton, S. and Miles, J., Eds., Grune and Stratton, New York, 1983, 115-132.
157. Laitinen, L. V., Longitudinal myelotomy for spasticity, in Neurosurgery for Spasticity, Sindou, M., Abbott, R., and Keravel, Y., Eds., Spinger-Verlag, York, 1991, 183-186.
158. Lipton, S., Percutaneous cordotomy, in Textbook of Pain, Wall, P. D. and Melzack, R., Eds., Churchill Livingstone, New York, 1989, 832-839.
159. Rosomoff, H. L., Carroll, F., Brown, J., and Sheptak, P., Percutaneous radiofrequency cervical cordotomy technique, J. Neurosurg., 23, 639-644, 1965.
160. Tasker, R. R. and Cardosa de Carvalho, G. T., Central pain of spinal cord origin, in Neurosurgical Management of Pain, North, R. B. and Levy, R. M., Eds., Springer-Verlag, New York, 1997, 110-116.
161. Bischof, W., Die longitudinale myelotomie, ZBL Neurochir., 11,79-88, 1951.
162. Spiller, W. G. and Martin, E., The treatment of persistent pain of organic origin in the lower part of the body by division of the antero-lateral column of the spinal cord, JAMA, 58, 1489-1490, 1912.
163. Hassenbusch, S. J., Surgical management of cancer pain, in Neurosurgery Clinics of North America, Gildenberg, P. L. L., Ed., W.B. Saunders Company, Philadelphia, 1995, 127-134.
164. Shieff, C. and Nasbold, B. S., Stereotactic mesencephalotomy, in Neurosurgery Clinics of North America, Friedman, W. A., Ed., W.B. Saunders Company, Philadelphia, 1990, 825-840.
165. Siegfried, J., Destructive stereotactic procedures for spasticity directed to the brain and the cerebellum, in Neurosurgery for Spasticity, Sindou, M., Abbott, R., and Keravel, Y., Eds., Spinger-Verlag, New York, 1991, 187-190.
166. Tasker, R. R. and Kiss, Z. H. T., The role of the thalamus in functional neurosurgery. in Neurosurgery Clinics of North America, Gildenberg, P. L., Ed., W.B. Saunders Company, Philadelphia, PA, 1995, 73-104.
167. Tasker, R. R., Stereotactic neurosurgery, in Textbook of Pain, Wall, P. D. and Melzack, R., Eds., Churchill Livingstone, New York, 1989, 840-855.
168. Burchiel, K. J., Thalamotomy for movement disorders, in Neurosurgery Clinics of North America, Gildenberg, P. L., Ed., W.B. Saunders Company, Philadelphia, PA, 1995, 55-71.
169. Tasker, R. R., Thalamotomy, in Neurosurgery Clinics of North America, Friedman, W. A., Ed., W.B. Saunders Company, Philadelphia, PA, 1990, 841-864.
170. Waltz, J. M., Reynolds, L. O., and Riklan, M., Multi-lead spinal cord stimulation for control of motor disorders, Appl. Neurophysiol., 44, 244-257, 1981.
171. Gildenberg, P. L., Management of movement disorders. An overview, in Neurosurgery Clinics of North America, Gildenberg, P. L., Ed., W.B. Saunders Company, Philadelphia, PA, 1995, 43-53.
172. Hitchcock, E. R., Special stereotactic techniques: stereotactic lesions of the spinal cord and pons, in Stereotactic Neurosurgery, Heilbrun, M. P., Ed., William & Wilkins, Baltimore, MD, 1988, 185-194.
173. Gildenberg, P. L., Stereotactic surgery: present and past, in Stereotactic Neurosurgery, Heilbrun, M. P., Ed., William & Wilkins, Baltimore, MD, 1988, 1-16.
174. Gildenberg, P. L., The history of stereotactic neurosurgery, in Neurosurgery Clinics of North America, Friedman, W. A., Ed., W.B. Saunders Company, Philadelphia, PA, 1990, 765-780.
175. Young, R. F., Jacques, D. S., Rand, R. W., and Copcutt, B. R., Medial thalamotomy with the Leksell Gamma Knife for treatment of chronic pain. [Review] [74 refs] Acta Neurochirurgica - Supplementum, 62, 105-110, 1994.
176. Ganz, E., Future developmepts in stereotactic neurosurgery, in Stereotactic Neurosurgery, Heilbrun, M. P., Ed., William & Wilkins, Baltimore, MD, 1988, 247-256.
177. Gildenberg, P. L. and De Vaul, R. A., The Chronic Pain Patient, Basel, Karger, 1985, 97.
178. Cook, A. W. and Weinstein, S. P., Chronic dorsal column stimulation in multiple sclerosis, N.Y. St. J. Med., 73, 2868-2872, 1973.
179. Illis, L. S., Sedgwick, E. M., and Tallis, R., Spinal cord stimulation in mutiple sclerosis: clinical results, J. Neurol. Neurosurg. Psychiat., 43, 1-14, 1980.
180. Shealy, C. N., Mortimer, J. T., and Reswick, J., Electrical inhibition of pain by stimulation of the dorsal colun: preliminary clinical reports, Anesth. Analgesia, 46, 489-491, 1967.
181. Gybels, J. and Van Roost, D., Spinal cord stimulation for spasticity, in Neurosurgery for Spasticity, Sindou, M., Abbott, R., and Keravel, Y., Eds., Spinger-Verlag, New York, 1991, 73-81.
182. Krainick, J. U. and Thoden, U., Dorsal column stimulation, in Textbook of Pain, Wall, P. D. and Melzack, R., Eds., Churchill-Livingstone, Edinburgh, 1989, 920-924.
183. Siegfried, J., Deepbrain and cerebellar stimulation for spasticity, in Neurosurgery for Spasticity, Sindou, M., Abbott, R., and Keravel, Y., Eds., Spinger-Verlag, New York, 1991, 83-87.
184. North, R. B. and Roark, G. L., Spinal cord stimulation for chronic pain, in Neurosurgery Clinics of North America, Gildenberg, P. L., Ed, W.B. Saunders Company, Philadelphia, PA, 1995, 145-155.
185. Turner, J. A., Loeser, J. D., and Bell, K. G., Spinal cord stimulation for chronic low back pain: a systematic literature synthesis, Neurosurgery, 37, 1088-1096, 1995.
186. Barolat, G., Experience with 509 plate electrodes implanted epidurally from C1 to L1, Stereotactic Functional Neurosurg., 61(2), 60-79.
187. Richardson, D. E., Deep brain stimulation for the relief of chronic pain, in Neurosurgery Clinics of North America, Gildenberg, P. L., Ed., W.B. Saunders Company, Philadelphia, PA, 1995, 135-144.
188. Young, R. F., Brain stimulation, in Textbook of Pain, Wall, P. D. and Melzack, R., Eds., Churchill Livingstone, 1989, 925-931.
189. Young, R. F., Brain stimulation, in Neurosurgery Clinics of North America, Friedman, W. A., Ed., W.B. Saunders Company, Philadelphia, PA, 1990, 865-880.
190. Young, R. F., Sterotactic methods in the management of pain, in Stereotactic Neurosurgery, Heilbrun, M. P., Ed., William & Wilkins, Baltimore, MD, 1988, 149-160.
191. Hosobuchi, Y., Subcortical electrical stimulation for control of intractable pain in humans, J. Neurosurg., 64, 543-553, 1986.
192. Tasker, R. R. and North, R., Cordotomy and myelotomy, in Neurosurgical Management of Pain, North, R. B. and Levy, R. M., Springer-Verlag, New York, 1997, 191-220.
193. Simpson, R. K., Jr., Edmondson, E. A., Contant, C. F., and Collier, C. L., Transdermal fentanyl as treatment for chronic low back pain, J. Pain Symp. Manage., 14, 218-224, 1997.
194. Maron, J. and Loeser, J. D., Spinal opioid infusions in the treatment of chronic pain of nonmalignant origin, Clin. J. Pain, 12, 174-179, 1996.
195. Erickson, D. L., Lo, J., and Michelson, M., Control of intractable spasticity with intrathecal morphine sulfate, Neurosurgery, 24, 236-238, 1989.
196. Hansebout, R. R., Blight, A. R., Fawcett, S., and Reddy, K., 4-aminopyridine in chronic spinal cord injury: a controlled, double-blind, crossover study in eight patients, J. Neurotrauma, 10(1), 1-18, 1993.
197. Middleton, J. W., Siddall, P. J., Walker, S., Molloy, A. R., and Rutkowski, S. B., Intrathecal clonidine and baclofen in the management of spasticity and neuropathic pain following spinal cord injury: a case study, Arch. Phys. Med. Rehab., 77(8), 824-826, 1996.
198. Siddall, P. J., Gray, M., Rutkowski, S., and Cousins, M. J., Intrathecal morphine and clonidine in the management of spinal cord injury pain: a case report, Pain, 59(1), 147-148, 1994.
199. Taira, T., Kawamura, H., Tanikawa, T., Iseki, H., Kawabatake, H., and Takakura, K., A new approach to control central deafferentation pain: spinal intrathecal baclofen, Stereotactic Functional Neurosurg., 65(1-4), 101-105, 1995.
200. Decq, P. and Keravel, Y., Drug pump technical description, operative procedure and postoperative management, in Neurosurgery for Spasticity, Sindou, M., Abbott, R., and Keravel, Y., Eds., Spinger-Verlag, New York, 1991, 97-101.
201. Decq, P. and Keravel, Y., Pharmacological bases of intrathecal baclofen administration, in Neurosurgery for Spasticity, Sindou, M., Abbott, R., and Keravel, Y., Eds., Spinger-Verlag, New York, 1991, 91-93.